What if you invested $1000 in COO on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, The Cooper Companies, Inc. has delivered an average annual return of 14.2%. The stock peaked in 2009 with a massive +104.7% gain, while investors faced a downturn in 2008 (-56.8%). Overall, the stock finished in the green 13 times out of 20 years.
Avg Return
+14.2%
Win Rate
65%
13W - 7L
Best
+104.7%
2009
Worst
-56.8%
2008
Performance Consistency
About The Cooper Companies, Inc.
Visit Website ↗The Cooper Companies, Inc. is a global medical device company that operates primarily through two business units: CooperVision and CooperSurgical. The company focuses on ophthalmology and surgical markets, providing contact lenses, fertility products, and medical devices.
Key Business Segments
CooperVision
Manufactures and distributes a wide range of contact lenses for various vision correction needs, including daily disposables, monthly disposables, and specialty lenses.
CooperSurgical
Provides products and services for women's healthcare, including fertility solutions, medical devices, and genetic testing.
Key Innovations
- ✓Pioneered the development of extended-wear contact lenses, offering greater convenience to users.
- ✓A leader in women's healthcare and fertility products, contributing to advancements in reproductive medicine.
Historical Milestones
The Cooper Companies is founded as Martin H. Smith Co.
The company enters the contact lens business with the acquisition of British lens maker GlobalVision.
CooperVision introduces Permalens, the first contact lens approved for 30-day continuous wear.
The company is renamed The Cooper Companies, Inc.
CooperSurgical acquires Generate Life Sciences, expanding its portfolio of fertility and genetic services.